MRC Epidemiology Unit
An international team led by researchers at the MRC Epidemiology Unit has used a cross-platform approach across several large human studies to identify hundreds of novel genetic variants that regulate […]
Consortium led by Unit researchers develops open platform to help discover COVID-19 drugs
An international consortium led by MRC researchers has developed an open access platform to help prioritise drug discovery and repurposing efforts for the current COVID-19 pandemic. The platform provides information on […]
Unit scientists join call for urgent action to address global diabetes epidemic
Researchers from the MRC Epidemiology Unit are part of the international team behind a new report in The Lancet summarising the best evidence for effectively managing and preventing diabetes. This […]
Open-access reference genetic dataset for the world’s largest study of incident type 2 diabetes
Type 2 diabetes is a chronic metabolic disease characterised by elevated levels of glucose in the blood, and presents a major and growing global public health challenge. While both genes […]
Researchers uncover genetic marker associated with fatty liver disease
The link between a specific genetic marker and severity of non-alcoholic fatty liver disease (NAFLD) has been validated in this study by researchers from several institutions and organisations, including the […]
MRC Epidemiology Unit launches study to monitor COVID-19 in 12,000 Cambridgeshire residents
Participants in Cambridgeshire’s Fenland Study are being invited to join an innovative study that will use a home-administered blood sampling device to find out how many have evidence in their […]
Study highlights potential for ‘liquid health check’ to predict disease risk
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of […]
Discovery of genetic variants that protect against obesity and type 2 diabetes could lead to new weight loss medicines
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge. The […]
Circulating glycine is genetically associated with lower risk of coronary heart disease
A new cross-platform meta-analysis of genome-wide association studies for glycine in more than 80,000 participants, led by Dr Claudia Langenberg and PhD student Laura Wittemans of our Aetiology of Diabetes Programme, and published […]
Gene variations that reduce ability to store fat around the hips linked to higher risk of diabetes and heart attacks
People who are less likely to put on excess fat around their hips due to their genes are at higher risk of type 2 diabetes and heart attacks, according to […]